JPS59104385A - オキサジアゾリル−イミダゾ−〔1,4〕ベンゾジアゼピン誘導体、その製法及びこれを含有する中枢神経系疾患治療剤 - Google Patents

オキサジアゾリル−イミダゾ−〔1,4〕ベンゾジアゼピン誘導体、その製法及びこれを含有する中枢神経系疾患治療剤

Info

Publication number
JPS59104385A
JPS59104385A JP58213456A JP21345683A JPS59104385A JP S59104385 A JPS59104385 A JP S59104385A JP 58213456 A JP58213456 A JP 58213456A JP 21345683 A JP21345683 A JP 21345683A JP S59104385 A JPS59104385 A JP S59104385A
Authority
JP
Japan
Prior art keywords
formula
imidazo
benzodiazepine
hydrogen
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58213456A
Other languages
English (en)
Japanese (ja)
Other versions
JPS635031B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
クラウス・チコ・ブレ−ストル−プ
イエルゲン・アンデルス・クリステンセン
モ−ゲンス・エンゲルストフト
フランク・ヴエ−トイエ−ン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of JPS59104385A publication Critical patent/JPS59104385A/ja
Publication of JPS635031B2 publication Critical patent/JPS635031B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP58213456A 1982-11-16 1983-11-15 オキサジアゾリル−イミダゾ−〔1,4〕ベンゾジアゼピン誘導体、その製法及びこれを含有する中枢神経系疾患治療剤 Granted JPS59104385A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK510282A DK151808C (da) 1982-11-16 1982-11-16 Analogifremgangsmaade til fremstilling af oxadiazolylimidazo-oe1,4aa-benzodiazepinderivater
DK5102/82 1982-11-16

Publications (2)

Publication Number Publication Date
JPS59104385A true JPS59104385A (ja) 1984-06-16
JPS635031B2 JPS635031B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-02-01

Family

ID=8139462

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58213456A Granted JPS59104385A (ja) 1982-11-16 1983-11-15 オキサジアゾリル−イミダゾ−〔1,4〕ベンゾジアゼピン誘導体、その製法及びこれを含有する中枢神経系疾患治療剤

Country Status (10)

Country Link
US (1) US4507313A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0109921B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS59104385A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE32721T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3375785D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK151808C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (3) ES8504196A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI78095C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE56233B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO163820C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60161989A (ja) * 1984-01-19 1985-08-23 エフ・ホフマン―ラ ロシユ アーゲー イミダゾジアゼピン誘導体
JPS62249985A (ja) * 1986-04-16 1987-10-30 ノヴォ ノルディスク アクティーゼルスカブ ベンゾジアゼピン誘導体、その製法、並びにそれを使用する中枢神経病治療剤

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA845757B (en) * 1983-08-25 1985-04-24 Hoffmann La Roche Benzodiazepine derivatives
AU587802B2 (en) * 1985-03-08 1989-08-31 Ferrosan A/S Novel oxadiazolyl imidazobenzodiazepine derivatives and methods of preparing such compounds
EP0202441B1 (en) * 1985-05-17 1988-11-17 A/S Ferrosan Oxadiazolylimidazobenzodiazepines, process for their preparation and pharmaceutical compositions
DK476885D0 (da) * 1985-10-17 1985-10-17 Ferrosan As Heterocycliske forbindelser og fremgangsmaader til fremstilling heraf
US4622321A (en) * 1985-05-17 1986-11-11 As Ferrosan Oxadiazolylimidazobenzodiazepine, compositions, and method
US4745112A (en) * 1985-05-17 1988-05-17 A/S Ferrosan Oxadiazolylimidazobenzodiazepine, compositions, and method III
ES2011448B3 (es) * 1985-10-17 1990-01-16 As Ferrosan Preparacion de un compuesto heterocido y uso del mismo
FI880814A7 (fi) * 1987-03-10 1988-09-11 Hoffmann La Roche Imidazodiazepin-derivat.
GB8823475D0 (en) * 1988-10-06 1988-11-16 Merck Sharp & Dohme Chemical compounds
CA2015336A1 (en) * 1989-05-19 1990-11-19 F. Hoffmann-La Roche Ag Imidazodiazepines for the treatment of neurological symptoms
US4904654A (en) * 1989-07-26 1990-02-27 Merck & Co., Inc. 7-chloro-5,6-dihydro-3-(5-(2-hydroxy-isopropyl)-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo-4H-imidazo[1,5a][1,4]benzodiazepine
US4939139A (en) * 1989-07-26 1990-07-03 Merck & Co., Inc. 7-chloro-5,6-dihydro-3-(5-(1,2-dihydroxy-isopropyl)-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo-4H-imidazo[1,5A][1,4]benzodiazepine
GB8923008D0 (en) * 1989-10-12 1989-11-29 Roussel Lab Ltd Chemical compounds
GB8927928D0 (en) * 1989-12-11 1990-02-14 Roussel Lab Ltd Chemical compounds
US5428031A (en) * 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
US5317018A (en) * 1992-06-09 1994-05-31 Armin Walser Benzodiazepines and compositions for treating anxiety and panic disorders, and idiopathic and psychomotor epilepsy
JPH09505597A (ja) * 1993-11-22 1997-06-03 メルク エンド カンパニー インコーポレーテッド 3−アシルアミノベンゾアゼピン類
US5439906A (en) * 1993-11-22 1995-08-08 Merck & Co., Inc. Antiarrhythmic benzodiazepines
CA2143246C (en) * 1994-03-16 2000-08-22 Thierry Godel Imidazodiazepines
CZ285008B6 (cs) * 1994-08-18 1999-04-14 Merck & Co., Inc. 2,3-dihydro-1-(2,2,2-trifluorethyl)-2-oxo-5-fenyl-1H-1,4-benzodiazepinové deriváty a farmaceutický prostředek s jejich obsahem
US5631251A (en) * 1995-06-07 1997-05-20 Merck & Co., Inc. 5-cyclopropyl-1,4 benzodiazepine-2-ones
US5700797A (en) * 1995-06-07 1997-12-23 Merck & Co, Inc. N-(2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl)-3-amides
US5691331A (en) * 1995-06-07 1997-11-25 Merck & Co., Inc. N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
CA2222491A1 (en) * 1995-06-07 1996-12-19 Merck & Co., Inc. Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
US5726171A (en) * 1995-06-07 1998-03-10 Merck & Co Inc N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1H-benzo B! 1,4!diazepin-3yl)-acetamides
US20090054412A1 (en) * 2007-08-20 2009-02-26 John Alan Kemp Treatment of Sleep Disorders
KR101589314B1 (ko) * 2007-08-20 2016-01-28 에보텍 인터내셔널 게엠베하 수면 장애의 치료
US8119629B2 (en) 2007-10-03 2012-02-21 Bristol-Meyers Squibb Company Carboxamide GABAA α2 modulators
US10071427B2 (en) * 2014-09-05 2018-09-11 Mazak Corporation Vertical machine tool apparatus and method

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE422580B (sv) * 1975-08-07 1982-03-15 Hoffmann La Roche Analogiforfarande for framstellning av imidazo (1,5-a)(1,4)diazepin-foreningar
CA1143728A (en) * 1979-10-04 1983-03-29 Max Gerecke Imidazodiazepine derivatives
JPS57123180A (en) * 1980-12-17 1982-07-31 Schering Ag 3-substituted beta-carboline, manufacture and psychotropic drug containing same
CA1184175A (en) * 1981-02-27 1985-03-19 Walter Hunkeler Imidazodiazepines
US4352817A (en) * 1981-02-27 1982-10-05 Hoffmann-La Roche Inc. Imidazo-diazepines and their use
CA1174673A (en) * 1981-02-27 1984-09-18 Walter Hunkeler Imidazodiazepines

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60161989A (ja) * 1984-01-19 1985-08-23 エフ・ホフマン―ラ ロシユ アーゲー イミダゾジアゼピン誘導体
JPS62249985A (ja) * 1986-04-16 1987-10-30 ノヴォ ノルディスク アクティーゼルスカブ ベンゾジアゼピン誘導体、その製法、並びにそれを使用する中枢神経病治療剤

Also Published As

Publication number Publication date
ATE32721T1 (de) 1988-03-15
NO834187L (no) 1984-05-18
ES529149A0 (es) 1985-09-01
FI834137A7 (fi) 1984-05-17
JPS635031B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-02-01
DE3375785D1 (en) 1988-04-07
EP0109921B1 (en) 1988-03-02
IE832644L (en) 1984-05-15
NO163820B (no) 1990-04-17
EP0109921A1 (en) 1984-05-30
DK151808C (da) 1988-06-20
ES8507144A1 (es) 1985-09-01
ES529150A0 (es) 1985-09-01
US4507313A (en) 1985-03-26
NO163820C (no) 1990-08-01
ES8507143A1 (es) 1985-09-01
ES527295A0 (es) 1985-04-16
FI78095B (fi) 1989-02-28
IE56233B1 (en) 1991-05-22
DK151808B (da) 1988-01-04
DK510282A (da) 1984-05-17
FI78095C (fi) 1989-06-12
FI834137A0 (fi) 1983-11-11
ES8504196A1 (es) 1985-04-16

Similar Documents

Publication Publication Date Title
JPS59104385A (ja) オキサジアゾリル−イミダゾ−〔1,4〕ベンゾジアゼピン誘導体、その製法及びこれを含有する中枢神経系疾患治療剤
US5260303A (en) Imidazopyridines as serotonergic 5-HT3 antagonists
KR940010034B1 (ko) 헤테로사이클릭 퀴녹살린 화합물의 제조방법
CN110997661A (zh) 环丙基脲甲酰肽2受体和甲酰肽1受体激动剂
TWI244472B (en) Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
SK2592002A3 (en) Tricyclic inhibitors of poly(adp-ribose) polymerases
CA2770712A1 (en) Heterocyclic compounds as janus kinase inhibitors
JP2004510764A (ja) 代謝共役型グルタミン酸受容体拮抗剤
WO2011082266A2 (en) Substituted heterocyclic compounds
JP2010013475A (ja) 新規な置換ピラゾール誘導体
JP2016523923A (ja) Rock阻害剤としての三環式ピリド−カルボキサミド誘導体
PT98929B (pt) Processo para a preparacao de antagonistas de receptores muscarinicos, nomeadamente compostos azabi- ou triciclicos
JP2008543866A (ja) 三環式オピオイドモジュレーター
TW202206413A (zh) Gpr52調節劑及其使用方法
JPS59106491A (ja) ベンゾキサジン化合物
JPH0542435B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP3803268B2 (ja) アザビシクロアルカン誘導体とその治療的使用
WO1994000449A1 (en) Benzimidazole compounds
KR100961287B1 (ko) 헤테로-비시클릭 crf 길항제
US8268854B2 (en) Aza-beta-carbolines and methods of using same
ES2842289T3 (es) Compuestos para tratar el síndrome del dolor y otros trastornos
RU2369601C2 (ru) Новые производные бензимидазола и их применение в качестве лекарственных средств
JPH0751577B2 (ja) 複素環キナゾリン化合物、その製造方法、並びに用途
TWI304404B (en) Halogen substituted benzodiazepine derivatives
JP2002509150A (ja) Gaba受容体のリガンドとしてのトリアゾロピリダジン誘導体